Genegoggle logo

Genegoggle jobs and careers

Poland

About Genegoggle

Genegoggle offers a solution for creating particles that accurately distinguish between cancer and healthy cells. We have built a unique tool that allows designing next generation compounds for drug discovery. Currently developed drugs target cancer cells while damaging healthy tissues. Designing selective delivery system to a certain type of cells lies at the foundation of precision medicine. Genegoggle’s disruptive approach is the response to this challenge.

Founded in 2021 by Jakub Mieczkowski, Marcin Kruczyk and Michal Marzecki.

Founded
2021
Employees
1 to 10
Headquarters
Poland

Leadership

The top of Genegoggle's org chart, with how many people report into each leader.

JMPhoto of Jakub Mieczkowski

Jakub Mieczkowski

Co-Founder